Cidara Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2022 to Q4 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Cidara Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2022 to Q4 2024.
  • Cidara Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -13.8K %, a 11784% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Operating Margin for 2024 was -13.8K %, a 11784% decline from 2023.
  • Cidara Therapeutics, Inc. annual Operating Margin for 2023 was -116 %, a 124% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -13.8K -13.7K -11784% Oct 1, 2024 Dec 31, 2024
Q3 2024 1.71K +1.75K Jul 1, 2024 Sep 30, 2024
Q2 2024 -15.2K -15.2K -383856% Apr 1, 2024 Jun 30, 2024
Q1 2024 -719 -704 -4780% Jan 1, 2024 Mar 31, 2024
Q4 2023 -116 -64.2 -124% Oct 1, 2023 Dec 31, 2023
Q3 2023 -43.3 Jul 1, 2023 Sep 30, 2023
Q2 2023 -3.97 Apr 1, 2023 Jun 30, 2023
Q1 2023 -14.7 Jan 1, 2023 Mar 31, 2023
Q4 2022 -52 Oct 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.